CONTINUE TO SITE ➞

Don't miss tomorrow's biopharma industry news

Let BioPharma Dive's free newsletter keep you informed, straight from your inbox.

Daily Dive M-F

Commercialization Weekly Every Wednesday

Gene Therapy Weekly Every Thursday

Emerging Biotech Weekly Every Tuesday

By signing up to receive our newsletter, you agree to our Terms of Use and Privacy Policy. You can unsubscribe at anytime.

Deep Dive
Library
Events
Press Releases

Pharma
Biotech
FDA
Clinical Trials
Deals
Drug Pricing
Gene Therapy

What We're Reading: Page 51

Industry reads hand-picked by our editors

Jul 16, 2024

Nature News
This kids’ brain cancer is incurable — but immune therapy holds promise
Fierce Biotech
Sotio taps Biocytogen to create bispecific ADCs in $326M deal
ApexOnco
A second-line degrader battle beckons

Jul 15, 2024

The New York Times
Promised Cures, Tainted Cells: How Cord Blood Banks Mislead Parents
Reuters
Novo Nordisk faces scrutiny on Capitol Hill for pulling Levemir insulin from US market
Axios
Medicare proposes payment for digital mental health therapies
FirstWord Pharma
Legend jumps on takeout chatter amid Carvykti success

Jul 12, 2024

Nature Biotechnology News
CAR-Ts sweep into autoimmunity
Bloomberg Law
Slimmed-Down Drug Patent Crackdown Bill Progresses in Senate
ApexOnco
Roche declares KRAS war on Amgen and Bristol
Bloomberg
Health Care Is About to Get Even More Litigious

Jul 11, 2024

Science
Weight loss drugs without the nausea? Mouse study suggests it may be possible
Reuters
Bird flu response in Michigan sparks COVID-era worry on farms
Bloomberg
Health-Care Companies Are Sending Your Data to Big Tech

Jul 10, 2024

Reuters
Most patients stop using Wegovy, Ozempic for weight loss within two years
ApexOnco
Reality Bites again for Amgen
Science
The Next Paxlovid

Jul 09, 2024

Reuters
Novo Nordisk shares down after analysis finds Lilly drug leads to better weight loss
Regulatory Focus
FDA draft guidance aims to give companies leeway to address medical misinformation
Undark
Haunting the Human Genome Project: A Question of Consent

Jul 08, 2024

CNN
Popular weight-loss and diabetes medications linked to lower risk of some cancers, study finds
Stat
Boehringer Ingelheim loses Medicare drug price negotiation case
Bloomberg
A World-First Psychedelics Experiment Is Unfolding in Australia
The Wall Street Journal
Why the Walmart Model Doesn’t Work in Healthcare

Previous Next

Get the free newsletter

Subscribe to BioPharma Dive for top news, trends & analysis

Email:

Select Newsletter: Daily Dive M-F
Select Newsletter: Commercialization Weekly Every Wednesday
Select Newsletter: Gene Therapy Weekly Every Thursday
Select Newsletter: Emerging Biotech Weekly Every Tuesday
Select user consent: By signing up to receive our newsletter, you agree to our Terms of Use and Privacy Policy. You can unsubscribe at anytime.

A valid email address is required. Please select at least one newsletter.

Library resources

Survey Report
The Evolution of Outsourced Buffer Production in Manufacturing Custom content for Thermo Fisher Scientific
Playbook
How to Unlock A Successful ICH E6(R3) Implementation Custom content for WCG
Playbook
Successful Biomarker-Driven Cancer Drug Development Custom content for Labcorp

View all

Company Announcements

View all | Post a press release

Events

View all | Promote an event

Industry Intel

Developing an Array of Diverse Vaccine Platforms Webinar - on demand • Provided by BioPharma Dive's studioID; Sponsored content by Novavax in partnership with studioID
Enhance Drug Discovery with CADD and Agentic AI on Rescale, AWS, and NVIDIA Webinar - on demand • Provided by Amazon Web Services (AWS), NVIDIA, and Rescale
AI-Powered Biomarker Discovery: From Screening to Translational Insights Webinar - on demand • Provided by Danaher

Explore

About
Editorial Team
Contact Us
Newsletter
Purchase Licensing Rights
Press Releases
What We're Reading

Reach our audience

Advertising
Post a press release
Promote an event

Related Publications

Healthcare Dive
MedTech Dive

Industry Dive is an Informa TechTarget business.

This website is owned and operated by Informa TechTarget, part of a global network that informs, influences and connects the world's technology buyers and sellers. All copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. TechTarget, Inc.'s registered office is 275 Grove St. Newton, MA 02466.

Home
- Pharma
- Biotech
- FDA
- Clinical Trials
- Deals
- Drug Pricing
- Gene Therapy
Deep Dive
Library
Events
Press Releases

Get BioPharma Dive in your inbox

The free newsletter covering the top industry headlines

Email:

Select Newsletter: Daily Dive M-F
Select Newsletter: Commercialization Weekly Every Wednesday
Select Newsletter: Gene Therapy Weekly Every Thursday
Select Newsletter: Emerging Biotech Weekly Every Tuesday
Select user consent: By signing up to receive our newsletter, you agree to our Terms of Use and Privacy Policy. You can unsubscribe at anytime.

A valid email address is required. Please select at least one newsletter.